Tuesday, March 17, 2026

NewJeans’ Emotional Farewell in Hong Kong Amid Legal Battle with ADOR

NewJeans pauses activities due to a court order, expressing gratitude to fans while prioritizing their rights and well-being.

U.S.-ROK Alliance: How the New Defense Strategy Affects China Relations in 2026

U.S. Deputy Secretary Colby emphasizes stronger U.S.-ROK ties to counter China's influence amidst evolving defense strategies.

Hyundai, Ingalls Join Forces to Drive Innovation in Shipbuilding

HD Hyundai partners with Huntington Ingalls to boost shipbuilding efficiency and technology, aiming for U.S. market entry.

Tag: botulinum toxin

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Huons BioPharma’s Botulinum Toxin HUTOX Set to Transform the Chinese Market

Huons BioPharma partners with iMaker Technology to supply botulinum toxin, aiming for a strong market presence in China.

Discover the Excellence of Botulax and Revolax at Thailand’s Largest Dermatology Conference

Hugel showcased its HA filler Revolax and botulinum toxin products at Thailand's largest dermatology conference, enhancing medical engagement.

Hugel’s Record-Breaking 2025 Financials: How Botulax and HA Fillers Drive 14% Revenue Growth

Hugel reports record 2025 financials with strong sales in toxins, fillers, and cosmetics, focusing on global market expansion.

CKDB-501A vs. Botox: Can CKD BiO’s New Botulinum Toxin Compete in China’s Booming Market?

Jongkundang Bio has successfully completed Phase 3 trials in China's botulinum toxin market, signaling global expansion.

Botox Faces New Challenger: Chong Kun Dang’s Toxin Shows Non-Inferiority in China Study

Chong Kun Dang's CKDB-501A shows non-inferiority to Botox in Phase 3 trials for treating glabellar lines, with promising safety data.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.